[go: up one dir, main page]

PL3976012T3 - Donosowe podawanie ketaminy pacjentom z klasterowym bólem głowy - Google Patents

Donosowe podawanie ketaminy pacjentom z klasterowym bólem głowy

Info

Publication number
PL3976012T3
PL3976012T3 PL20754342.2T PL20754342T PL3976012T3 PL 3976012 T3 PL3976012 T3 PL 3976012T3 PL 20754342 T PL20754342 T PL 20754342T PL 3976012 T3 PL3976012 T3 PL 3976012T3
Authority
PL
Poland
Prior art keywords
ketamine
intranasal administration
cluster headache
headache patients
patients
Prior art date
Application number
PL20754342.2T
Other languages
English (en)
Inventor
Per Holm
Ole Pedersen
John Claude Krusz
Original Assignee
Afyx Therapeutics A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afyx Therapeutics A/S filed Critical Afyx Therapeutics A/S
Publication of PL3976012T3 publication Critical patent/PL3976012T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL20754342.2T 2019-05-31 2020-05-29 Donosowe podawanie ketaminy pacjentom z klasterowym bólem głowy PL3976012T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962855543P 2019-05-31 2019-05-31
PCT/IB2020/000432 WO2020240279A1 (en) 2019-05-31 2020-05-29 Intranasal administration of ketamine to cluster headache patients

Publications (1)

Publication Number Publication Date
PL3976012T3 true PL3976012T3 (pl) 2024-06-24

Family

ID=72046932

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20754342.2T PL3976012T3 (pl) 2019-05-31 2020-05-29 Donosowe podawanie ketaminy pacjentom z klasterowym bólem głowy

Country Status (8)

Country Link
US (2) US20220218627A1 (pl)
EP (2) EP3976012B1 (pl)
DK (1) DK3976012T3 (pl)
ES (1) ES2977185T3 (pl)
FI (1) FI3976012T3 (pl)
PL (1) PL3976012T3 (pl)
PT (1) PT3976012T (pl)
WO (1) WO2020240279A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022123607A1 (en) * 2020-12-10 2022-06-16 Rubicon Research Private Limited Pharmaceutical formulations of esketamine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543434A (en) 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
US6248789B1 (en) * 1996-08-29 2001-06-19 Stuart L. Weg Administration of ketamine to manage pain and to reduce drug dependency
CN104902883A (zh) * 2012-08-23 2015-09-09 斯图亚特·L·韦格 抗焦虑组合物、制剂及使用方法
SG10201802104QA (en) 2013-03-15 2018-05-30 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
US20180177744A1 (en) * 2016-12-22 2018-06-28 Gary Jay Method of treating pain and depression using a hybrid mixture of s-ketamine and r-ketamine
US20180177743A1 (en) * 2016-12-22 2018-06-28 Gary Jay Method of treating pain using racemic mixture of s-ketamine and r-ketamine
CN112423789A (zh) * 2017-12-22 2021-02-26 詹森药业有限公司 用于治疗抑郁症的艾司氯胺酮

Also Published As

Publication number Publication date
FI3976012T3 (fi) 2024-04-05
US20220218627A1 (en) 2022-07-14
US20230000796A1 (en) 2023-01-05
EP3976012B1 (en) 2024-03-20
WO2020240279A1 (en) 2020-12-03
EP4364812A2 (en) 2024-05-08
DK3976012T3 (da) 2024-04-15
EP4364812A3 (en) 2024-09-04
EP3976012A1 (en) 2022-04-06
ES2977185T3 (es) 2024-08-20
PT3976012T (pt) 2024-04-09

Similar Documents

Publication Publication Date Title
IL267250A (en) Enzymatic production of d-allulose
ZA201805634B (en) Conjugate of therapeutic enzymes
MX2020012046A (es) Ciclopropilamina como inhibidor de la desmetilasa 1 especifica de lisinas (lsd1).
IN2014CH00247A (pl)
PL3558024T3 (pl) Produkcja preparatów beta-laktoglobuliny
ZA201801299B (en) Silica to high purity silicon production process
ZA202102826B (en) Enzymatic production of hexoses
IL291273A (en) Intranasal administration of asketamine
EP3209767A4 (en) A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase)
SG11202108304PA (en) Enzymatic production of mannose
ZA201804397B (en) Biosynthetic gene cluster of carrimycin
HUE058627T2 (hu) Új eljárás nagy tisztaságú prosztaglandinok elõállítására
GB2539016B (en) Manufacture of graphene by plasma-enhanced CVD
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
GB201906515D0 (en) Improvements relating to inhalers
PL3976012T3 (pl) Donosowe podawanie ketaminy pacjentom z klasterowym bólem głowy
IN2013CH04906A (pl)
ZA201707735B (en) Methods of targeting ape1/ref-1 to inhibit hypoxia signaling genes
IL289338A (en) Therapeutic interactions of leucomethylthionine
IL288538A (en) An enzymatic product of fructose
GB201709136D0 (en) New therapeutic uses of enzyme inhibitors
PT3393517T (pt) Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave
IL304191A (en) elagolix administration methods
IN2013CH05383A (pl)
GB201701707D0 (en) Improvements to operations of engines